Moderna Inc.’s COVID-19 vaccine appeared set for regulatory authorization this week after US Food and Drug Administration staff endorsed it as safe and effective in documents released Tuesday.
Moderna Inc.’s COVID-19 vaccine appeared set for regulatory authorization this week after US Food and Drug Administration staff endorsed it as safe and effective in documents released Tuesday.